Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Open Label Randomized Controlled Trial Determir Vs Neutral Protamine Hagedorn (NPH) In Pregnant Women: DETERMINE Study

NCT05124457 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05124457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Open Label Randomized Controlled Trial Determir Vs Neutral Protamine Hagedorn (NPH) In Pregnant Women: DETERMINE Study
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Recruiting
Start date
February 1, 2022
Completion date
June 30, 2025
Enrollment
336 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, gestational diabetes